Hand-foot Syndrome Induced by High-dose, Short-term, Continuous 5-Fluorouracil Infusion

By Chiara S.   Nobile M.T.   Barzacchi C.   Sanguineti O.   Vincenti M.   Di Somma C.   Meszaros P.   Rosso R.  

European Journal of Cancer, Vol. 33, Iss. 6, 1997-05 ,pp. : 967-969

Elsevier

Access to resources Recommend Favorite

Comparison of Continuous Infusion and Bolus Administration of Ifosfamide in Children

By Boddy A.V.   Yule S.M.   Wyllie R.   Price L.   Pearson A.D.J.   Idle J.R.  

European Journal of Cancer, Vol. 31, Iss. 5, 1995-01 ,pp. : 785-790

Elsevier

Access to resources Recommend Favorite

Bolus injection (2-4min) versus short-term (10-20min) infusion of 5-fluorouracil in patients with advanced colorectal cancer: a prospective randomised trial

By Glimelius B.   Jakobsen A.   Graf W.   Berglund A.   Gadeberg C.   Hansen P.   Kjaer M.   Brunsgaard N.   Sandberg E.   Lindberg B.   Sellstrom H.   Lorentz T.   Pahlman L.   Gustavsson B.  

European Journal of Cancer, Vol. 34, Iss. 5, 1998-04 ,pp. : 674-678

Elsevier

Access to resources Recommend Favorite

Susceptibility of fibromatosis cells in short-term culture to ifosfamide: a possible experimental treatment in clinically aggressive cases

By Verrill Mark W.   Coley Helen M.   Judson Ian R.   Fisher Cyril  

Sarcoma, Vol. 3, Iss. 2, 1999-09 ,pp. : 79-84

Informa Healthcare

Access to resources Recommend Favorite

Ifosfamide and Continuous Infusion Etoposide in Advanced Adult Soft Tissue Sarcoma. A Scandinavian Sarcoma Group Phase II Study

By Saeter G.   Alvegard T.A.   Monge O.R.   Strander H.   Turesson I.   Klepp R.   Soderberg M.   Wist E.   Raabe N.   Erlanson M.   Solheim .P.   Hannisdal E.  

European Journal of Cancer, Vol. 33, Iss. 10, 1997-09 ,pp. : 1551-1558

Elsevier

Access to resources Recommend Favorite